NYSE:BIOA (BIOA) (BIOA) Stock Price, News & Analysis → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free BIOA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$0.01▼$0.0350-Day Range N/A52-Week Range$0.01▼$2.88Volume15.51 million shsAverage Volume2.97 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (BIOA) alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About (BIOA) Stock (NYSE:BIOA)BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now BIOA Stock News HeadlinesApril 21, 2024 | markets.businessinsider.comBioArctic And Eisai Collaborate On Evaluating BAN2802 For Alzheimer's DiseaseApril 16, 2024 | finanznachrichten.deThe Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic ABApril 23, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… April 12, 2024 | morningstar.comCamurus AB CAMXApril 10, 2024 | finance.yahoo.comBioArctic's focus on Sustainable Innovation qualifies company for new ESG Responsibility Index at Nasdaq StockholmApril 6, 2024 | finance.yahoo.comB Jun 2024 50.000 callApril 6, 2024 | finance.yahoo.comB Sep 2024 40.000 putApril 6, 2024 | finance.yahoo.comB Sep 2024 30.000 putApril 23, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… April 1, 2024 | finance.yahoo.comSubmission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's disease to the U.S. FDA completedMarch 22, 2024 | finance.yahoo.comLecanemab deliberations at the CHMP regarding the Marketing Authorisation Application in the EU have been rescheduled due to procedural reasonsMarch 16, 2024 | finance.yahoo.comB Apr 2024 30.000 putMarch 16, 2024 | finance.yahoo.comB Apr 2024 40.000 callMarch 16, 2024 | finance.yahoo.comB Apr 2024 45.000 callMarch 11, 2024 | finance.yahoo.comBioArctic: New data on lecanemab presented at the 2024 AD/PD™ congressMarch 7, 2024 | finance.yahoo.comBioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conferenceFebruary 29, 2024 | finanznachrichten.deBioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD congressFebruary 29, 2024 | finance.yahoo.comBioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congressFebruary 17, 2024 | morningstar.comBioiasis AD BIOAFebruary 6, 2024 | finanznachrichten.deBioArctic: Sales of Leqembi® totaled 1.1 billion yen in the fourth quarter 2023February 6, 2024 | finance.yahoo.comSales of Leqembi® totaled 1.1 billion yen in the fourth quarter 2023January 11, 2024 | finance.yahoo.comThe European Medicines Agency's Scientific Advisory Group (SAG) to discuss the Marketing Authorisation Application for lecanemab: BioArcticJanuary 9, 2024 | finanznachrichten.deBioArctic: Leqembi® approved for the treatment of Alzheimer's disease in ChinaJanuary 9, 2024 | finance.yahoo.comLeqembi® approved for the treatment of Alzheimer's disease in ChinaDecember 13, 2023 | finance.yahoo.comLEQEMBI® to be launched in Japan for Alzheimer's disease on December 20December 12, 2023 | finanznachrichten.deBioArctic: LEQEMBI® to be launched in Japan for Alzheimer's disease on December 20December 8, 2023 | finance.yahoo.comBioArctic AB (publ) (BIOA-B.ST)See More Headlines Receive BIOA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (BIOA) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/09/2016Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:BIOA CUSIPN/A CIK1534287 Webwww.bio-amber.com Phone+1-612-7474423FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesRaymond J. Land (Age 72)Chairman of the Board Richard P. EnoChief Financial Officer, DirectorMario SettinoChief Financial OfficerMichael A. Hartmann (Age 48)Executive Vice President James Millis (Age 59)Chief Technology Officer Robert FrostDirectorKurt W. Briner (Age 70)Independent Director Heinz Haller (Age 62)Independent Director Ellen B. Richstone (Age 65)Independent Director Kenneth W Wall (Age 66)Independent Director More Executives BIOA Stock Analysis - Frequently Asked Questions How were (BIOA)'s earnings last quarter? (BIOA) (NYSE:BIOA) posted its earnings results on Tuesday, August, 9th. The biotechnology company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.02. The biotechnology company had revenue of $2.50 million for the quarter, compared to the consensus estimate of $2.37 million. What other stocks do shareholders of (BIOA) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (BIOA) investors own include ProQR Therapeutics (PRQR), Flexion Therapeutics (FLXN), Rite Aid (RAD), LadRx (CYTR), Intellipharmaceutics International (IPCIF), Biopharmx (BPMX), EyePoint Pharmaceuticals (EYPT), MoneyGram International (MGI), AbbVie (ABBV) and Aurinia Pharmaceuticals (AUPH). This page (NYSE:BIOA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
